Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
OCULAR THERAPEUTIX, INC | Chief Operating Officer and Chief Financial Officer | Common Stock | 209K | $1.89M | $9.02 | Aug 29, 2024 | Direct |
OCULAR THERAPEUTIX, INC | Chief Operating Officer and Chief Financial Officer | Stock Option (Right to Buy) | 33.6K | Aug 29, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OCUL | OCULAR THERAPEUTIX, INC | Aug 29, 2024 | 2 | $0 | 4 | Sep 3, 2024 | Chief Operating Officer and Chief Financial Officer |
OCUL | OCULAR THERAPEUTIX, INC | Feb 3, 2024 | 3 | $30.2K | 4 | Feb 6, 2024 | Chief Financial Officer |
OCUL | OCULAR THERAPEUTIX, INC | Jan 31, 2024 | 1 | -$31.8K | 4 | Feb 2, 2024 | Chief Financial Officer |
OCUL | OCULAR THERAPEUTIX, INC | Feb 6, 2023 | 1 | -$27.5K | 4 | Feb 8, 2023 | Chief Financial Officer |
OCUL | OCULAR THERAPEUTIX, INC | Jan 30, 2023 | 2 | $0 | 4 | Feb 1, 2023 | Chief Financial Officer |
OCUL | OCULAR THERAPEUTIX, INC | Feb 3, 2022 | 2 | $0 | 4 | Feb 7, 2022 | Chief Financial Officer |